Andrea Moser, PA
Physician Assistant · Oklahoma City, OKNPI 1558332981
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 431 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,073, more than ten times the $162 reported in 2021. Among physician assistant clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 431 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$1K
- Dexcom, Inc.$962
- Medtronic$899
- Lilly USA, LLC$797
- Xeris Pharmaceuticals, Inc.$616
- Novo Nordisk$597
- plus $4K from 30 others
What the payments were for
- Travel & lodging$2312%
- Food & beverage$9,03297%
- Education$100%
- Gifts$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 45 | $1,070 |
| Dexcom, Inc. | 45 | $962 |
| Medtronic | 13 | $899 |
| Lilly USA, LLC | 44 | $797 |
| Xeris Pharmaceuticals, Inc. | 34 | $616 |
| Novo Nordisk | 31 | $597 |
| Abbott | 20 | $510 |
| Sanofi-aventis U.S. LLC | 24 | $488 |
| Bayer | 24 | $408 |
| Tandem Diabetes Care, Inc. | 15 | $344 |
| Amgen | 18 | $294 |
| Boehringer Ingelheim | 16 | $284 |
| Mannkind Corporation | 10 | $233 |
| AbbVie | 13 | $195 |
| Sequel Med Tech, LLC | 10 | $183 |
| Recordati_rare_diseases_inc. | 8 | $177 |
| BETA Bionics, Inc. | 9 | $144 |
| Cequr Corporation | 3 | $135 |
| Ascensia Diabetes Care US Inc. | 5 | $119 |
| Insulet Corporation | 6 | $117 |
| IBSA Pharma Inc. | 4 | $115 |
| Radius Health, Inc. | 4 | $102 |
| Chiesi USA, Inc. | 4 | $81 |
| Ascendis Pharma Endocrinology Inc | 3 | $65 |
| Astellas Pharma US Inc | 4 | $62 |
| Antares Pharma, Inc. | 3 | $51 |
| Amneal Pharmaceuticals LLC | 3 | $49 |
| Kyowa Kirin, Inc. | 2 | $40 |
| AstraZeneca(2 entities) | 2 | $36 |
| Pfizer | 2 | $35 |
| Lifescan, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Nevro Corp. | 1 | $22 |
| Novartis | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$246
- DEXCOM G6 TRANSMITTER$233
- INPEN SMART INSULIN DELIVERY SYSTEM$201
- FREESTYLE LIBRE 3$143
- RYBELSUS$118
- Kerendia$116
- Korlym$113
- CeQur Simplicity$111
How this compares
$9,333 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 393 | $655,436 |
| MounjaroTirzepatide | 306 | $546,610 |
| JardianceEmpagliflozin | 365 | $439,257 |
| Tresiba Flextouch U-200Insulin Degludec | 228 | $269,446 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 76 | $133,989 |
| FarxigaDapagliflozin Propanediol | 92 | $107,818 |
| TrulicityDulaglutide | 68 | $91,705 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 61 | $72,070 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 58 | $61,699 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 29 | $48,544 |
| JanuviaSitagliptin Phosphate | 27 | $40,910 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 44 | $40,333 |
| Novolog FlexpenInsulin Aspart | 112 | $37,549 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $37,370 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $36,669 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $597 | $685,458444 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $797 | $660,316444 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Synjardy | $284 | $519,202440 claims |
| AstraZenecaFarxiga | $36 | $107,81892 claims |
| AmgenProlia | $294 | $31,42118 claims |
| AbbVieSynthroid | $195 | $4,02452 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $49 | $3,661311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Oklahoma City
- Jennifer SmithOklahoma City$134K
- Sarah HawkOklahoma City$23K
- Brooke CromerOklahoma City$14K
- Mary Jane RorickOklahoma City$14K
- Alma HintzeOklahoma City$14K
- Emily McLainOklahoma City$13K
- Deniz AktasOklahoma City$13K
- Jovonne SmithOklahoma City$12K
- Anthony SharpOklahoma City$11K
- Whitney PriceOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.